Nextech Invest
Zurich-based VC investing in emerging biotechnology companies focused on transformative cancer medicines.
About
Nextech Invest is a venture capital firm founded in 1998 and headquartered in Zurich, Switzerland. It specializes in investing in early-stage biotechnology companies worldwide, particularly those developing transformative cancer medicines. The firm nurtures its portfolio through critical scientific validation and value creation stages, with a focus on precision oncology and cell therapy innovation. Its portfolio includes companies like Stipple Bio and Revolution Medicines.
Fund detail is a Pro feature
Assets under management, the full fund history with vintages, the partner roster and what each one covers, and the portfolio mapping back to company pages — all included with Pro.
See Pro — $20/mo